Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

ClinicalTrials.gov ID: NCT00128531

Public ClinicalTrials.gov record NCT00128531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of a New Leuprolide Acetate 3.75 mg Depot Formulation, GP-Pharm S.A., When Given as Palliative Treatment to Prostate Cancer Patients

Study identification

NCT ID
NCT00128531
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GP-Pharm
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • leuprolide acetate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2005
Primary completion
Not listed
Completion
Oct 31, 2007
Last update posted
Nov 13, 2007

2005 – 2007

United States locations

U.S. sites
15
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209
Desert Oasis Cancer Center Casa Granda Arizona 85222
Southwest Florida Urologic Associates Fort Myers Florida 33907
Advanced Research Institute, Inc. New Port Richey Florida 34652
Florida Urology Specialists Sarasota Florida 34237
Regional Urology Shreveport Louisiana 71106
Lakeside Urology Saint Joseph Michigan 49085
Hamilton Urology, P.A. Hamilton New Jersey 08690
Lawrenceville Urology Lawrenceville New Jersey 08648
AccuMed Research Associates Garden City New York 11530
Urological Surgeons of Long Island Garden City New York 11530
Hudson Valley Urology Kingston New York 12401
Hudson Valley Urology Poughkeepsie New York 12601
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Urology Associates, PC Nashville Tennessee 37209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00128531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2007 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00128531 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →